Online citations, reference lists, and bibliographies.
← Back to Search

Nanoparticle-based Strategies For Cancer Immunotherapy And Immunodiagnostics.

A. Grimaldi, M. Incoronato, M. Salvatore, A. Soricelli
Published 2017 · Medicine, Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
Although recent successes in clinical trials are strengthening research focused on cancer immunology, the poor immunogenicity and off-target side effects of immunotherapeutics remain major challenges in translating these promising approaches to clinically feasible therapies in the treatment of a large range of tumors. Nanotechnology offers target-based approaches, which have shown significant improvements in the rapidly advancing field of cancer immunotherapy. Here, we first discuss the chemical and physical features of nanoparticulate systems that can be tuned to address the anticancer immune response, and then review recent, key examples of the exploited strategies, ranging from nanovaccines to NPs revising the tumor immunosuppressive microenvironment, up to immunotherapeutic multimodal NPs. Finally, the paper concludes by identifying the promising and outstanding challenges the field of emerging nanotechnologies is facing for cancer immunotherapy.
This paper references
10.1038/nmat3355
Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy.
Jineun Park (2012)
10.1002/smll.200800582
Biocompatible polymer-nanoparticle-based bimodal imaging contrast agents for the labeling and tracking of dendritic cells.
Y. Lim (2008)
10.1056/NEJMoa1200694
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
J. Brahmer (2012)
10.1016/S0168-3659(01)00412-6
Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?
L. Thiele (2001)
10.1016/j.biomaterials.2015.04.016
Superparamagnetic MRI probes for in vivo tracking of dendritic cell migration with a clinical 3 T scanner.
Y. Xu (2015)
10.1021/bm101482r
Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles.
Zhanguo Yue (2011)
10.1073/pnas.0804897106
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
Fiona A. Sharp (2009)
10.1371/journal.pone.0061646
Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice
I. Kourtis (2013)
10.1002/adhm.201500441
Effect of shape, size, and aspect ratio on nanoparticle penetration and distribution inside solid tissues using 3D spheroid models.
Rachit Agarwal (2015)
10.1021/la504668c
Macrophage uptake of Janus particles depends upon Janus balance.
Yuan Gao (2015)
10.1021/mp800032f
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.
M. Dobrovolskaia (2008)
10.1088/0957-4484/20/11/115103
The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells.
Ángeles Villanueva (2009)
10.1016/j.copbio.2016.02.001
Biomaterials for enhancing anti-cancer immunity.
Sandeep T. Koshy (2016)
10.1016/j.jconrel.2011.12.017
PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
Y. Zhuang (2012)
10.1002/anie.201203193
Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo.
I. Lee (2012)
10.1016/j.jconrel.2016.11.013
Tumor‐targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment
Meirong Huo (2017)
10.1016/j.addr.2009.03.009
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
P. Aggarwal (2009)
10.1016/j.jconrel.2015.09.062
Nanoparticulate immunotherapy for cancer.
Chintan H. Kapadia (2015)
10.1021/acsnano.5b07253
Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
Ane Ruiz-de-Angulo (2016)
10.1016/j.addr.2016.01.007
Impact of particle elasticity on particle‐based drug delivery systems☆
Aaron C. Anselmo (2017)
10.1023/B:PHAM.0000033012.16152.5d
Composition and Surface Charge of DNA-Loaded Microparticles Determine Maturation and Cytokine Secretion in Human Dendritic Cells
S. Jilek (2004)
10.1182/BLOOD-2006-08-039446
A novel proteoliposomal vaccine elicits potent antitumor immunity in mice.
M. C. Popescu (2007)
10.1016/j.biomaterials.2014.05.077
Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy.
Y. Yoshizaki (2014)
10.1088/0957-4484/22/11/115101
The effects of particle size, density and shape on margination of nanoparticles in microcirculation.
R. Toy (2011)
10.1016/j.jbiomech.2008.03.021
The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows.
F. Gentile (2008)
10.1021/acsnano.5b01939
Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT Imaging.
R. Meir (2015)
10.1002/smll.201102002
How shape influences uptake: interactions of anisotropic polymer nanoparticles and human mesenchymal stem cells.
L. Florez (2012)
10.1038/nm.2198
Therapeutic cell engineering using surface-conjugated synthetic nanoparticles
M. Stephan (2010)
10.1056/NEJMoa1305133
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
O. Hamid (2013)
10.1016/j.actbio.2012.06.006
Differential functional effects of biomaterials on dendritic cell maturation.
J. Park (2012)
10.1007/s00262-008-0539-9
The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route
W. Ge (2008)
10.1111/j.1365-2567.2005.02268.x
Enhanced and prolonged cross‐presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles
H. Shen (2006)
10.1016/J.JCONREL.2006.06.020
Stable cationic microparticles for enhanced model antigen delivery to dendritic cells.
C. Wischke (2006)
10.1039/c1nr10166h
The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses.
Yifan Ma (2011)
10.1038/nbt.3071
Injectable, spontaneously assembling inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy
J. Kim (2015)
10.1056/NEJMoa1001294
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
P. Kantoff (2010)
10.1038/nnano.2011.149
A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy.
N. Cho (2011)
10.1371/journal.pone.0063550
Gold Nanoparticle Delivery of Modified CpG Stimulates Macrophages and Inhibits Tumor Growth for Enhanced Immunotherapy
A. Lin (2013)
10.1016/J.JCONREL.2006.01.006
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles.
S. T. Reddy (2006)
10.1016/j.jcyt.2013.09.006
Magnetic resonance and near-infrared imaging using a novel dual-modality nano-probe for dendritic cell tracking in vivo.
Y. Chen (2014)
10.1016/j.nano.2010.12.004
Multimodal imaging of dendritic cells using a novel hybrid magneto-optical nanoprobe.
Patrick S Mackay (2011)
10.1016/S0005-2736(97)00122-3
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose.
C. Oussoren (1997)
10.1073/pnas.0801763105
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton (2008)
10.1007/s00262-005-0013-x
Interleukin-2/liposomes potentiate immune responses to a soluble protein cancer vaccine in mice
Dean Johnston (2005)
10.1021/nn500205b
Modulation of drug resistance in ovarian adenocarcinoma using chemotherapy entrapped in hyaluronan-grafted nanoparticle clusters.
K. Cohen (2014)
10.1038/nbt1332
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
S. T. Reddy (2007)
10.1016/j.biomaterials.2017.01.017
A simple and powerful co-delivery system based on pH-responsive metal-organic frameworks for enhanced cancer immunotherapy.
F. Duan (2017)
10.1016/j.vaccine.2009.03.034
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy.
Stacey L. Demento (2009)
10.1016/j.ccr.2008.12.018
Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment.
M. Kortylewski (2009)
10.1126/scitranslmed.3007563
Therapeutic Inflammatory Monocyte Modulation Using Immune-Modifying Microparticles
D. Getts (2014)
10.4049/jimmunol.0802113
Chitin Is a Size-Dependent Regulator of Macrophage TNF and IL-10 Production1
Carla A Da Silva (2009)
10.1016/j.biomaterials.2011.01.067
Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery.
Zhiping Zhang (2011)
10.2217/imt.12.26
Particle-mediated delivery of cytokines for immunotherapy.
D. Christian (2012)
10.1016/j.vaccine.2008.01.030
TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses.
Eva Schlosser (2008)
10.1016/j.it.2016.08.003
Harnessing Nanoparticles for Immune Modulation: (Trends in Immunology 36, 419-427; July 2016).
Daniel R. Getts (2016)
10.1002/mrm.22519
Longitudinal tracking of human dendritic cells in murine models using magnetic resonance imaging
Karen C. Briley‐Saebo (2010)
10.1016/j.biomaterials.2013.02.024
Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles.
Armando Stano (2013)
10.1002/jbm.a.35970
Impact of molecular weight on the intrinsic immunogenic activity of poly(beta amino esters).
James I Andorko (2017)
10.1021/nn404211j
Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles.
B. Sun (2013)
10.1158/0008-5472.CAN-11-1264
Targeted therapeutic remodeling of the tumor microenvironment improves an HER-2 DNA vaccine and prevents recurrence in a murine breast cancer model.
D. Liao (2011)
10.1007/978-3-319-41129-3_2
Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications
Saurabh Bhatia (2016)
10.1007/s11095-013-1224-z
Comparison of PLA Microparticles and Alum as Adjuvants for H5N1 Influenza Split Vaccine: Adjuvanticity Evaluation and Preliminary Action Mode Analysis
W. Zhang (2013)
10.1081/LPR-120004790
ROLE OF COMPLEMENT ACTIVATION IN HYPERSENSITIVITY REACTIONS TO DOXIL AND HYNIC PEG LIPOSOMES: EXPERIMENTAL AND CLINICAL STUDIES
J. Szebeni (2002)
10.2147/IJN.S112432
Improved proliferation of antigen-specific cytolytic T lymphocytes using a multimodal nanovaccine
B. Li (2016)
10.1021/nn405033r
A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease
Zoe N Hunter (2014)
10.1016/j.biomaterials.2013.08.064
Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(γ-glutamic acid) nanoparticles.
F. Shima (2013)
10.1177/019262339902700112
The Toxicology of Interleukin-12: A Review
B. Car (1999)
10.1016/J.YMETH.2006.05.016
Pathogen recognition and development of particulate vaccines: does size matter?
S. Xiang (2006)
10.3892/OR_00000517
The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following different administration routes.
W. Ge (2009)
10.1038/nature10673
Cancer immunotherapy comes of age
I. Mellman (2011)
10.1016/j.biomaterials.2012.03.041
Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype.
Stacey L. Demento (2012)
10.1073/pnas.1216893110
Particle shape enhances specificity of antibody-displaying nanoparticles
Sutapa Barua (2013)
10.1021/nl500618u
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
R. Fang (2014)
10.1016/j.jconrel.2011.11.013
Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy.
Z. Huang (2012)
10.1016/j.biomaterials.2011.05.013
Simultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response.
Young-Woock Noh (2011)
10.1208/s12249-014-0099-6
Particle Margination and Its Implications on Intravenous Anticancer Drug Delivery
Erik J Carboni (2014)
10.3390/vaccines3030662
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
Yuchen Fan (2015)
10.1002/anie.201105187
Polyvalent immunostimulatory nanoagents with self-assembled CpG oligonucleotide-conjugated gold nanoparticles.
M. Wei (2012)
10.3390/cancers3043856
Cytokines in Cancer Immunotherapy
S. Lee (2011)
10.4049/jimmunol.176.12.7335
Efficient Immunization and Cross-Priming by Vaccine Adjuvants Containing TLR3 or TLR9 Agonists Complexed to Cationic Liposomes1
Karen Zaks (2006)
10.1021/BC049951I
Toxicity of gold nanoparticles functionalized with cationic and anionic side chains.
Catherine M Goodman (2004)
10.1016/j.biomaterials.2015.07.053
Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma.
Y. Zhao (2015)
10.1586/erv.10.89
Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses
M. Oyewumi (2010)
10.1073/pnas.1603455113
Reporter nanoparticle that monitors its anticancer efficacy in real time
A. Kulkarni (2016)
10.1096/fj.06-6186fje
Methylation of the phosphate oxygen moiety of phospholipid‐methoxy(polyethylene glycol) conjugate prevents PEGylated liposome‐mediated complement activation and anaphylatoxin production
S. Moein Moghimi (2006)
10.1016/J.SBSR.2016.08.002
Multifunctional nanoparticle developments in cancer diagnosis and treatment
S. Parvanian (2017)
10.1021/nn500216y
Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment
Zhenghong Xu (2014)
10.1016/J.BIOMATERIALS.2006.10.034
The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles.
S. Fischer (2007)
10.1016/j.jconrel.2010.08.012
Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
D. Mohanan (2010)
10.1016/j.jconrel.2013.08.021
Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.
Zhenghong Xu (2013)
10.2217/17435889.3.3.343
Design opportunities for actively targeted nanoparticle vaccines.
T. Fahmy (2008)
10.1021/acsnano.5b00147
Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting.
Aaron C. Anselmo (2015)
10.1073/pnas.0706296105
Antigen kinetics determines immune reactivity
P. Johansen (2008)
10.1073/PNAS.0600997103
Role of target geometry in phagocytosis.
J. Champion (2006)
10.1021/mp200016d
Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigens.
Nijaporn Yanasarn (2011)
10.1016/J.NANTOD.2014.10.001
Nanoparticle design to induce tumor immunity and challenge the suppressive tumor microenvironment
Heleen Dewitte (2014)
10.3389/fimmu.2017.00239
Role of Metallic Nanoparticles in Vaccinology: Implications for Infectious Disease Vaccine Development
Lázaro Moreira Marques Neto (2017)
10.2217/nnm.13.67
Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy.
Songwei Tan (2014)
10.1016/j.jconrel.2015.09.069
Shape and size-dependent immune response to antigen-carrying nanoparticles.
S. Kumar (2015)
10.1002/cmmi.433
Labelling dendritic cells with SPIO has implications for their subsequent in vivo migration as assessed with cellular MRI.
Sonali N de Chickera (2011)
10.1039/c3nr06102g
Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles.
Shoshy Mizrahy (2014)
10.4049/jimmunol.178.5.2979
Targeting of Antigen to Dendritic Cells with Poly(γ-Glutamic Acid) Nanoparticles Induces Antigen-Specific Humoral and Cellular Immunity1
T. Uto (2007)
10.1016/j.addr.2011.05.016
Targeting the lymphatics using dendritic polymers (dendrimers).
L. M. Kaminskas (2011)
10.1007/s00262-015-1702-8
6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice
L. Jeanbart (2015)
10.1016/J.IT.2006.10.005
Targeting dendritic cells with biomaterials: developing the next generation of vaccines.
S. T. Reddy (2006)
10.1186/s13045-015-0219-0
Nivolumab plus ipilimumab in the treatment of advanced melanoma
K. Tsai (2015)
10.1021/mp500589c
Rapid and Persistent Delivery of Antigen by Lymph Node Targeting PRINT Nanoparticle Vaccine Carrier To Promote Humoral Immunity.
S. Mueller (2015)
10.1002/(SICI)1097-0215(19980911)77:6<901::AID-IJC17>3.0.CO;2-3
Biodistribution and tumor localization of stealth liposomal tumor necrosis factor‐α in soft tissue sarcoma bearing rats
Alexander H. van der Veen (1998)
10.3389/fchem.2014.00105
Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking
João Conniot (2014)
10.1023/A:1022271020390
Phagocytosis and Phagosomal Fate of Surface-Modified Microparticles in Dendritic Cells and Macrophages
L. Thiele (2004)
10.1039/c1cs15239d
Polysaccharides as building blocks for nanotherapeutics.
Shoshy Mizrahy (2012)
10.1016/j.jconrel.2015.05.022
Lymphatic-targeted cationic liposomes: A robust vaccine adjuvant for promoting long-term immunological memory.
C. Wang (2015)
10.1021/mp100356k
Multimodal imaging of nanovaccine carriers targeted to human dendritic cells.
L. Cruz (2011)
10.4049/jimmunol.173.5.3148
Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors1
T. Fifis (2004)
10.1016/J.IJPHARM.2005.03.035
Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model.
C. Foged (2005)
10.1016/J.VACCINE.2004.05.022
Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific tumour challenge in mice.
T. Fifis (2004)
10.1002/eji.200737984
Nanoparticles target distinct dendritic cell populations according to their size
V. Manolova (2008)



This paper is referenced by
Tissue-Engineered Vascular Grafts: Recellularisation and Surface Functionalisation with Hybrid Magnetic Nanomedicine Developed with Theranostic Potential
Tatiane Eufrásio da Silva (2018)
10.1016/j.ijpharm.2018.03.029
Nanoparticles for dendritic cell-based immunotherapy.
T. H. Tran (2018)
10.3390/molecules24244620
Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies
Marina A Dobrovolskaia (2019)
10.3390/nano8050315
Iron Oxide Colloidal Nanoclusters as Theranostic Vehicles and Their Interactions at the Cellular Level
A. Kostopoulou (2018)
10.1080/1744666X.2020.1762572
Nanoparticle-based immunotherapy: state of the art and future perspectives
M. Di Gioacchino (2020)
10.2147/IJN.S177418
Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape
A. Kermanizadeh (2018)
10.1016/j.mtadv.2020.100069
Pristine large pore benzene-bridged mesoporous organosilica nanoparticles as an adjuvant and co-delivery platform for eliciting potent antitumor immunity
Manasi Jambhrunkar (2020)
10.2174/1381612825666190708214240
Nanoparticles: Properties and Applications in Cancer Immunotherapy.
Alessandra Iscaro (2019)
10.1016/j.nano.2018.11.009
Ferritin nanoparticle-based SpyTag/SpyCatcher-enabled click vaccine for tumor immunotherapy.
Wenjun Wang (2019)
10.1002/adtp.201900115
Recent Advances in Particulate Adjuvants for Cancer Vaccination
Cui Song (2020)
10.1016/J.BIOMATERIALS.2018.03.036
Novel treatment strategies in cancer immunotherapy
H. Yoon (2018)
10.1016/j.biomaterials.2018.03.036
Engineering nanoparticle strategies for effective cancer immunotherapy.
H. Yoon (2018)
10.2217/nnm-2017-0345
Targeted delivery of miRNA-204-5p by PEGylated polymer nanoparticles for colon cancer therapy.
B. Zheng (2018)
10.2217/nnm-2018-0407
Electron microscopy in human diseases: diagnostic and research perspectives.
Manuel Scimeca (2019)
10.1016/bs.acr.2018.05.003
Nanotechnology Approaches to Improving Cancer Immunotherapy.
C. Hagan (2018)
10.3390/cancers11020176
Releasing the Immune System Brakes Using siRNAs Enhances Cancer Immunotherapy
Mouldy Sioud (2019)
10.1039/c9nr03510a
Influenza mimetic protein-polymer nanoparticles as antigen delivery vehicles to dendritic cells for cancer immunotherapy.
Chaeyeon Lee (2019)
10.1002/adtp.201800011
Multifunctional and Stimuli‐Responsive Magnetic Nanoparticle‐Based Delivery Systems for Biomedical Applications
H. Y. Yang (2018)
10.3390/biology9080202
Liposome-Based Bioassays
Jacopo Sforzi (2020)
Biofunctional iron oxide nanoparticles as vaccine adjuvants for enhanced anti-cancer immunotherapy
Bocanegra Gondan (2017)
10.3390/medicines5040114
Checkpoint Inhibition: Will Combination with Radiotherapy and Nanoparticle-Mediated Delivery Improve Efficacy?
Purushottam Lamichhane (2018)
Semantic Scholar Logo Some data provided by SemanticScholar